RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, CRLR was an”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“CRLR by itself cannot function as a receptor for CGRP as it needs to form complexes with accessory proteins from the RAMP family134.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
In the citing paper
“while for CGRP, its major receptors are calcitonin receptor like receptor (CRLR) and receptor activity modifying protein 1 (RAMP-1).”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
Citations
Cites
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612 · cited 1×
“Many receptors are not easily expressed in commonly used host cell lines: GABA b , eotaxin (CKR3”
BackgroundChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Teasdale, R. D., & Jackson, M. R. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.27 · Cited by 500 · cited 1×
“This pair of basic residues is similar to an endoplasmic-reticulum-retrieval moti”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor
Kapas, S., Catt, K. J., & Clark, A. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25344 · Cited by 288 · cited 1×
“Two related members of the ‘family A’ class of GPCRs, RDC1 and G10D, were then identified as receptors for CGRP and ADM, respectivel”
BackgroundCalcitonin gene-related peptide: Multiple actions, multiple receptors
Poyner, D. R. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90036-y · Cited by 225 · cited 1×
“These activities include the regulation of neuromuscular junctions, of antigen presentation within the immune system, of vascular tone and of sensory neurotransmissio”
BackgroundWang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., & Feuerstein, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · cited 1×
“and its messenger RNA is upregulated in CNS tissues that are subject to ischaemi”
BackgroundIdentification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor
Kapas, S., & Clark, A. J. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2847 · Cited by 175
Muff, R., Born, W., & Fischer, J. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330017 · Cited by 155
Cited by
Items 501–600 of 1,009
GPCR-Interacting Proteins, Major Players of GPCR Function
Maurice, P., Guillaume, J., Benleulmi‐Chaachoua, A., Daulat, A. M., Kamal, M. T., & Jockers, R. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00001-4 · Cited by 76
Benyahia, Z., Dussault, N., Cayol, M., Sigaud, R., Berenguer‐Daizé, C., Delfino, C., Tounsi, A., Garcia, S., Martin, P., Mabrouk, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14999 · Cited by 71
“It acts through the G proteincoupled receptor calcitonin receptor-like receptor (CLR), with specificity for AM being conferred by the receptor activity modifying protein 2 (RAMP2) and 3 (RAMP3) [15].”
BackgroundInfluentialProtein aggregates and proteostasis in aging: Amylin and β-cell function
Press, M., Jung, T., König, J., Grune, T., & Höhn, A. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.03.010 · Cited by 72
Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure
Cueille, C., Pidoux, E., de Vernejoul, M. C., Ventura‐Clapier, R., & Garel, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00487-4 · Cited by 72
Kurashige, C., Hosono, K., Matsuda, H., Tsujikawa, K., Okamoto, H., & Majima, M. (2014) · The FASEB Journal · doi:10.1096/fj.13-238998 · Cited by 67
“CGRP binds to CGRP receptors composed of RAMP1 and calcitonin receptor-like receptor (CLR) to modulate various functions, such as vasodilation and pain transmission (2, 3).”
BackgroundCNIH4 Interacts with Newly Synthesized GPCR and Controls Their Export from the Endoplasmic Reticulum
Sauvageau, É., Rochdi, M. D., Oueslati, M., Hamdan, F. F., Percherancier, Y., Simpson, J. C., Pepperkok, R., & Bouvier, M. (2014) · Traffic · doi:10.1111/tra.12148 · Cited by 74
“Well-characterized examples of these proteins include RAMP-1 that assists the trafficking of the calcitonin receptor-like receptor (12,13), MRAP that is needed for the cell surface targeting of the MC2 melanocortin receptor (14,15) as well as REEP for the odorant and taste receptors (16,17).”
BackgroundLoss of αCGRP Reduces Sound-Evoked Activity in the Cochlear Nerve
Maison, S. F., Emeson, R. B., Adams, J. C., Luebke, A. E., & Liberman, M. C. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00596.2003 · Cited by 67
Csáti, A., Tajti, J., Tuka, B., Edvinsson, L. I., & Warfvinge, K. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.058 · Cited by 67
Harikumar, K. G., Morfis, M. M., Lisenbee, C. S., Sexton, P. M., & Miller, L. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015776 · Cited by 67
“…calcitonin receptor and calcitonin-like receptor can both exist as homo-dimeric receptors (Seck et al., 2003; Heroux and Bouvier, 2005) in an analogous manner to each of the receptors in the current study, and RAMPs themselves clearly form homodimers (McLatchie et al., 1998; Sexton et al., 2001).”
BackgroundResultAmylin Selectively Signals Onto POMC Neurons in the Arcuate Nucleus of the Hypothalamus
Lutz, T. A., Coester, B., Whiting, L., Dunn-Meynell, A. A., Boyle, C. N., Bouret, S. G., Levin, B. E., & Le Foll, C. (2018) · Diabetes · doi:10.2337/db17-1347 · Cited by 68
“The amylin receptor (AMY) is composed of the core calcitonin receptor (CTR) A or B (2), which heterodimerizes with one or several receptor activity–modifying proteins (RAMP1, -2, and -3) (3,4).”
BackgroundRossi, S. G., Dickerson, I. M., & Rotundo, R. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211379200 · Cited by 67
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma
Dallmayer, M., Li, J., Ohmura, S., Rubío, R. A., Baldauf, M. C., Hölting, T. L. B., Musa, J., Knott, M. M. L., Stein, S., Cidre‐Aranaz, F., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1372-0 · Cited by 73
Sohn, I., Sheykhzade, M., Edvinsson, L. I., & Sams, A. G. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173205 · Cited by 67
Marvizón, J. C. G., Pérez, O. A., Song, B., Chen, W., Bunnett, N. W., Grady, E. F., & Todd, A. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.036 · Cited by 66
“Discussion Colocalization of CRLR and RAMP1 One critical issue in this study is whether the CRLR and RAMP1 proteins detected in our experiments dimerize to form CGRP receptors (McLatchie et al., 1998).”
BackgroundInfluentialStructure–activity relationships for α‐calcitonin gene‐related peptide
Watkins, H. A., Rathbone, D. L., Barwell, J., Hay, D. L., & Poyner, D. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12072 · Cited by 59
“CGRP also has high affinity at the AMY1 receptor, a receptor for amylin formed from the calcitonin receptor (CTR) and RAMP1 (Christopoulos et al., 1999; Poyner et al., 2002); indeed it exhibits higher potency than amylin at the receptor formed between RAMP1 and the D47 splice variant of the CTR (Qi et al., 2012).”
BackgroundInfluentialCalcitonin Gene-Related Peptide (CGRP) and Cluster Headache
Belin, A. C., Ran, C., & Edvinsson, L. I. (2020) · Brain Sciences · doi:10.3390/brainsci10010030 · Cited by 71
“The main functional unit of the receptor, CALCRL (also known as CLR or CRLR), can be linked to one of three RAMPs which, respectively, produces different receptors [57].”
BackgroundLeuthäuser, K., Gujer, R., Aldecoa, A., McKinney, R. A., Muff, R., Fischer, J. A., & Born, W. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510347 · Cited by 66
Amylin activates distributed CNS nuclei to control energy balance
Mietlicki-Baase, E. G., & Hayes, M. R. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.01.013 · Cited by 66
“The CTR alone has the highest affinity for calcitonin [25, 26], but enhanced selectivity for amylin binding is conferred by association with a RAMP [27, 28], of which there are three possible subtypes for the amylin receptor complex (RAMP1, RAMP2, RAMP3) [29].”
BackgroundCalcitonin gene-related peptide: an update on the biology
Recober, A., & Russo, A. F. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832b2427 · Cited by 65
Takahashi, K., Kikuchi, K., Maruyama, Y., Urabe, T., Nakajima, K., Sasano, H., Imai, Y., Murakami, O., & Totsune, K. (2005) · Peptides · doi:10.1016/j.peptides.2005.11.004 · Cited by 65
Verheggen, R., Bumann, K., & Kaumann, A. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704682 · Cited by 65
“Receptor activity modifying proteins, RAMPs, are modulators that determine the pharmacology of CGRP and other peptides (McLatchie et al., 1998).”
BackgroundNelson, C. P., & Challiss, R. A. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.005 · Cited by 67
Duvernay, M. T., Dong, C., Zhang, X., Robitaille, M., Hébert, T. E., & Wu, G. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00890.x · Cited by 71
Kuwasako, K., Cao, Y., Nagoshi, Y., Tsuruda, T., Kitamura, K., & Eto, T. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.207 · Cited by 66
“Human CTR2 (Kuestner et al., 1994) and the three hRAMPs (McLatchie et al., 1998) were modified to provide a consensus Kozak sequence as described previously (Aiyar et al., 1996).”
BackgroundMethodInfluentialKuwasako, K., Kitamura, K., Ito, K., Uemura, T., Yanagita, Y., Kato, J., Sakata, T., & Eto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108369200 · Cited by 69
Pankevych, H., Korkhov, V. M., Freissmuth, M., & Nanoff, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212918200 · Cited by 70
Ladoux, A., & Frelin, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006512200 · Cited by 68
Getting a Handle on Neuropharmacology by Targeting Receptor-Associated Proteins
Maher, M. P., Matta, J. A., Gu, S., Seierstad, M., & Bredt, D. S. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.001 · Cited by 64
CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?
Kamm, K. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.930383 · Cited by 64
“It is responsible for high affinity binding of CGRP and receptor trafficking (30, 31).”
BackgroundObesity treatment: novel peripheral targets
Field, B. C. T., Chaudhri, O. B., & Bloom, S. R. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03522.x · Cited by 64
Conner, A. C., Hay, D. L., Simms, J., Howitt, S. G., Schindler, M., Smith, D. M., Wheatley, M., & Poyner, D. R. (2005) · Molecular Pharmacology · doi:10.1124/mol.67.1.20 · Cited by 69
“This is consistent with observations that AM is less potent than CGRP at this receptor complex (McLatchie et al., 1998).”
BackgroundInvolvement of calcitonin gene-related peptide in control of human fetoplacental vascular tone
Dong, Y.-L., Vegiraju, S., Chauhan, M., Gangula, P. R., Hankins, G. D. V., Goodrum, L. A., & Yallampalli, C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00140.2003 · Cited by 69
“It is well recognized that the calcitonin receptor-like receptor (CRLR) functions as either a CGRP receptor or an adrenomedullin receptor depending on the expression of the type of receptor activity-modifying proteins (RAMPs) (32).”
BackgroundNilsson, C., Hansen, T. K., Rosenquist, C., Hartmann, B., Kodra, J. T., Lau, J. F., Clausen, T. R., Raun, K., & Sams, A. G. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.01.003 · Cited by 67
Sexton, P. M., Christopoulos, G., Christopoulos, A., Nylén, E., Snider, R. H., & Becker, K. L. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318170a554 · Cited by 64
Hershey, J. C., Corcoran, H. A., Baskin, E. P., Salvatore, C., Mosser, S. D., Williams, T. M., Koblan, K. S., Hargreaves, R. J., & Kane, S. A. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.10.010 · Cited by 64
Cardiac fibroblasts are major production and target cells of adrenomedullin in the heart in vitro
Tomoda, Y., Kikumoto, K., Isumi, Y., Katafuchi, T., Tanaka, A., Kangawa, K., Dohi, K., & Minamino, N. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00291-1 · Cited by 67
Udawela, M., Christopoulos, G., Tilakaratne, N., Christopoulos, A., Albiston, A. L., & Sexton, P. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021915 · Cited by 63
“First, [(125)I]CGRP was shown to cross-link to RAMP1 and CLR, indicating close proximity of RAMP1 and CLR at the cell membrane (Stangl et al., 1991; McLatchie et al., 1998).”
BackgroundGupta, S., Mehrotra, S., Villalón, C. M., Garrelds, I. M., VRIES, R. D., van Kats, J. P., Sharma, H. S., Saxena, P. R., & MaassenVanDenBrink, A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.020 · Cited by 63
Flahaut, M., Rossier, B. C., & Firsov, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112084200 · Cited by 67
Muff, R., Born, W., Lutz, T. A., & Fischer, J. A. (2004) · Peptides · doi:10.1016/j.peptides.2004.08.007 · Cited by 62
Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs
Ong, J. J. Y., Wei, D. Y., & Goadsby, P. J. (2018) · Drugs · doi:10.1007/s40265-018-0865-y · Cited by 67
Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis
Atanasova, K. R., & Reznikov, L. R. (2018) · Respiratory Research · doi:10.1186/s12931-018-0846-4 · Cited by 65
Nelson-Maney, N., Bálint, L., Beeson, A. L. S., Serafín, D., Kistner, B. M., Douglas, E. S., Siddiqui, A., Tauro, A. M., & Caron, K. M. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175616 · Cited by 63
“Moreover, global loss of the Ramp1 gene, which encodes a requisite chaperone protein required for CGRP signaling (33–36), also causes impaired lymphatic growth and function (37).”
BackgroundCalcitonin-like diuretic hormones in insects
Zandawala, M. (2012) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2012.06.006 · Cited by 62
“Mammalian CT receptor-like receptor (CLR) signaling is dependent on two types of accessory proteins: receptor activity modifying proteins (RAMPs) and receptor component protein (RCP) (Evans et al., 2000; McLatchie et al., 1998).”
BackgroundEgea, S. C., & Dickerson, I. M. (2012) · Endocrinology · doi:10.1210/en.2011-1459 · Cited by 62
“Previous studies have found that CLR and RAMP1 are required for efficient trafficking of both molecules to the cell surface (15, 30, 34).”
BackgroundResultProtective Role of α-Calcitonin Gene-Related Peptide in Cardiovascular Diseases
Kumar, A., Potts, J. D., & DiPette, D. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00821 · Cited by 68
New Migraine and Pain Research
Hargreaves, R. J. (2007) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00675.x · Cited by 62
Effects of calcitonin gene-related peptide and amylin on human osteoblast-like cells proliferation
Villa, I., Melzi, R., Pagani, F., Ravasi, F., Rubinacci, A., & GUIDOBONO, F. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00872-4 · Cited by 64
Reduced nociceptive behavior in islet amyloid polypeptide (amylin) knockout mice
Gebré‐Medhin, S., Mulder, H., Zhang, Y., Sundler, F., & Betsholtz, C. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00269-1 · Cited by 62
Dong, Y.-L., Green, K. E., Vegiragu, S., Hankins, G. D. V., Martin, E., Chauhan, M., Thota, C., & Yallampalli, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1481 · Cited by 68
“Primer sequences for CRLR and RAMP1 were derived from published sequences (12, 13).”
MethodKuwasako, K., Kitamura, K., Nagoshi, Y., Cao, Y., & Eto, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302571200 · Cited by 64
Adrenomedullin receptors: pharmacological features and possible pathophysiological roles
Kuwasako, K., Cao, Y., Nagoshi, Y., Kitamura, K., & Eto, T. (2004) · Peptides · doi:10.1016/j.peptides.2004.06.002 · Cited by 68
Karpa, K. D., Lidow, M. S., Pickering, M., Levenson, R. G., & Bergson, C. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.1071 · Cited by 72
“These proteins, termed RAMPs (receptoractivity modifying proteins) (McLatchie et al., 1998) are sensitive to the glycosylation state of the seven transmembrane domain receptors with which they interact and aid in directing the receptors to the plasma membrane.”
BackgroundGABAB receptor cell-surface export is controlled by an endoplasmic reticulum gatekeeper
Doly, S., Shirvani, H., Gätà, G., Meye, F. J., Emerit, M.-B., Enslen, H., Achour, L., Pardo‐López, L., Yang, S.-K., Armand, V., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.72 · Cited by 61
An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology
J Gingell, J., Simms, J., Barwell, J., Poyner, D. R., Watkins, H. A., Pioszak, A. A., Sexton, P. M., & Hay, D. L. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.12 · Cited by 59
Biosynthesis and trafficking of seven transmembrane receptor signalling complexes
Dupré, D. J., & Hébert, T. E. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.03.009 · Cited by 73
Serino, R., Ueta, Y., Hara, Y., Nomura, M. J., Yamamoto, Y., Shibuya, I., Hattori, Y., Kitamura, K., Kangawa, K., Russell, J. A., et al. (1999) · Endocrinology · doi:10.1210/endo.140.5.6717 · Cited by 65
Sonne, N., Karsdal, M. A., & Henriksen, K. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101109 · Cited by 63
“These are critical receptor components for the functionality of this receptor [33].”
BackgroundKim, T., & Hempstead, B. L. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.118 · Cited by 65
“…on interac- tion with a neuronally expressed syntaxin-like molecule, ODR-4 (Dwyer et al, 1998), and the surface localization of the calcitonin receptor-like receptor requires interaction with the type I transmembrane protein RAMPs (receptor activity modifying proteins) (McLatchie et al, 1998).”
BackgroundG protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)
Ferré, S., Ciruela, F., DESSAUER, C. W., González‐Maeso, J., Hébert, T. E., Jockers, R., Logothetis, D. E., & Pardo, L. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107977 · Cited by 61
“adrenomedullin (AM) or adrenomedullin 2/intermedin (AM2), depending on the subtype of RAMP co-expressed (McLatchie et al., 1998; Serafin et al., 2020).”
BackgroundCardioprotective Effect of Adrenomedullin in Heart Failure
Nishikimi, T., Yoshihara, F., Mori, Y., Kangawa, K., & Matsuoka, H. (2003) · Hypertension Research · doi:10.1291/hypres.26.s121 · Cited by 64
“(24) recently demonstrated that a seven-transmembrane receptor, the calcitonin receptor-like receptor (CRLR), can function as either a CGRP or an AM receptor, depending on the coexpression of a new family of three single transmembrane receptor activity modifying proteins (RAMPs).”
BackgroundIslet amyloid polypeptide in the islets of Langerhans: friend or foe?
Gebré‐Medhin, S., Olofsson, C. S., & Mulder, H. (2000) · Diabetologia · doi:10.1007/s001250051364 · Cited by 66
“Members of a previously unknown group of receptor-activity-modifying proteins (RAMPs) were, however, recently found to interact with the orphan calcitonin receptor-like receptor (CRLR) and determine its ligand specificity [45]; whereas the combination of RAMP1/CRLR results in a CGRP receptor, RAMP2/CRLR is an adrenome…”
BackgroundPositive inotropy mediated via CGRP receptors in isolated human myocardial trabeculae
Opgaard, O. S., Hasbak, P., VRIES, R. D., Saxena, P. R., & Edvinsson, L. I. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00233-8 · Cited by 62
Moreno, M., Cohen, Z., Stanimirovic, D. B., & Hamel, É. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199911000-00012 · Cited by 60
Lutz, T. A. (2022) · Appetite · doi:10.1016/j.appet.2022.105965 · Cited by 59
Yamamoto, K. I., Kakino, A., Takeshita, H., Hayashi, N., Li, L., Nakano, A., Yamamoto‐Hanasaki, H., Fujita, Y., Imaizumi, Y., Yokoyama, S., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-271627 · Cited by 59
Quillon, A., Fromy, B., & Debret, R. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.01.006 · Cited by 59
Wu, L., Pan, Y., Chen, G., Matsunami, H., & Zhuang, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.345884 · Cited by 65
“An analogous example would be the receptor activity-modifying proteins, which complex with the calcitonin receptor and calcitonin-like receptor to give receptor complexes with divergent ligand specificities (27).”
BackgroundReceptor and secreted targets of Wnt-1/β-catenin signalling in mouse mammary epithelial cells
Kenny, P. A., Enver, T., & Ashworth, A. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-3 · Cited by 61
“RAMP3-Calcitonin Receptor (CR) heterodimers form a functional receptor for amylin [50], and RAMP3-Calcitonin-Receptor-Like-Receptor (CRLR) heterodimers act as an adrenomedullin receptor [51].”
BackgroundInhibition of Calcitonin Gene‐Related Peptide Function: A Promising Strategy for Treating Migraine
Durham, P. L. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01215.x · Cited by 59
“RAMP1 functions to traffic mature CRL proteins to the surface of the cell membrane.(48) Structure-function investigations have demonstrated that an 18 amino acid sequence located at the N-terminus of the CRL is important for CGRP docking but is not involved in the activation of the mature CGRP receptor.”
BackgroundThe genetics of ACTH resistance syndromes
Metherell, L., Chan, L. F., & Clark, A. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.09.002 · Cited by 61
Research progress in calcitonin gene-related peptide and bone repair
Wang, Q., Qin, H., Deng, J., Xu, H., Liu, S., Weng, J., & Zeng, H. (2023) · Biomolecules · doi:10.3390/biom13050838 · Cited by 58
“This creates a CLR-RAMP1 dimer for CGRP to bind and function with CLR; thus, RAMP1 is essential for CLR function [9].”
Kusano, S., Kukimoto‐Niino, M., Hino, N., Ohsawa, N., Okuda, K., Sakamoto, K., Shirouzu, M., Shindo, T., & Yokoyama, S. (2012) · Protein Science · doi:10.1002/pro.2003 · Cited by 58
“1(A)].(8) CRLR belongs to the class B family of seven transmembrane-spanning G-protein coupled receptors (GPCRs), while RAMP2 is an accessory protein with a single transmembrane-spanning region.”
BackgroundBerenguer‐Daizé, C., Boudouresque, F., Bastide, C., Tounsi, A., Benyahia, Z., Acunzo, J., Dussault, N., Delfino, C., Baeza, N., Daniel, L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0691 · Cited by 58
Migraine: Experimental Models and Novel Therapeutic Approaches
Tardiolo, G., Bramanti, P., & Mazzon, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122932 · Cited by 58
“The structure of CGRP receptor is a complex of proteins composed as follows: a G-protein-coupled receptor named the calcitonin receptor-like receptor (CLR) [37]; a single transmembrane accessory protein named receptor activity-modifying protein 1 (RAMP1) [38] (needed to establish the binding of CGRP to CLR), and the r…”
BackgroundWatanabe, H., Takahashi, E., Kobayashi, M., Goto, M., Krust, A., Chambon, P., & Iguchi, T. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01825 · Cited by 64
“This is of interest because RAMP3 modifies the calcitonin gene-related receptor (CRLR), after which CRLR can serve as a receptor for ADM (McLatchie et al. 1998).”
BackgroundInfluentialNew Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors
Hoffmann, J., & Goadsby, P. J. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0155-4 · Cited by 60
Amylin: Localization, Effects on Cerebral Arteries and on Local Cerebral Blood Flow in the Cat
Edvinsson, L. I., Goadsby, P. J., & Uddman, R. (2001) · The Scientific World JOURNAL · doi:10.1100/tsw.2001.23 · Cited by 59
Crystal structure of the human receptor activity‐modifying protein 1 extracellular domain
Kusano, S., Kukimoto‐Niino, M., Akasaka, R., Toyama, M., Terada, T., Shirouzu, M., Shindo, T., & Yokoyama, S. (2008) · Protein Science · doi:10.1110/ps.036012.108 · Cited by 61
“The cell-surface CRLR RAMP1 heterodimer functions as a CGRP-specific receptor, while the CRLR RAMP2 and CRLR RAMP3 heterodimers are AM receptors with distinct affinities (McLatchie et al. 1998; Sexton et al. 2001; Born et al. 2002; Poyner et al. 2002).”
BackgroundInfluentialAntidromic vasodilatation and the migraine mechanism
Geppetti, P., Rossi, E., Chiarugi, A., & Benemei, S. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-011-0408-3 · Cited by 57
Watkins, H. A., Au, M., & Hay, D. L. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.005 · Cited by 59
Corato, A. D., Lisi, L., Capuano, A., Tringali, G., Tramutola, A., Navarra, P., & Russo, C. D. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.013 · Cited by 61
“The CGRP binding site is located on the seven transmembrane spanning protein CLR, while the flanking protein RAMP1 regulates the membrane transport of CLR and confers higher affinity for CGRP (McLatchie et al., 1998).”
The GTPase Rab43 Controls the Anterograde ER-Golgi Trafficking and Sorting of GPCRs
Li, C., Wei, Z., Fan, Y., Huang, W. Y., Su, Y., Li, H., Dong, Z., Fukuda, M., Khater, M., & Wu, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.011 · Cited by 57
“…and promote receptor delivery to the plasma membrane (Björk et al., 2013; Chen et al., 2009; Colley et al., 1991; Doly et al., 2015; Dwyer et al., 1998; Ferreira et al., 1996; Hay and Pioszak, 2016; McLatchie et al., 1998; Rodrigues et al., 2017; Sauvageau et al., 2014; Tai et al., 1999).”
Nikitenko, L. L., Blucher, N., Fox, S. B., Bicknell, R., Smith, D. M., & REES, M. C. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.02783 · Cited by 60
“Glycosidases F and H were used to differentiate between N-linked glycoproteins (McLatchie et al., 1998).”
BackgroundResultInfluentialEverest, H. M., Hislop, J. N., Harding, T. C., Uney, J. B., Flynn, A., Millar, R. P., & McArdle, C. A. (2001) · Endocrinology · doi:10.1210/endo.142.11.8503 · Cited by 57
Calcitonin gene-related peptide: role in airway homeostasis
Dakhama, A., Larsen, G. L., & Gelfand, E. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.01.006 · Cited by 60
Hay, D. L., Howitt, S. G., Conner, A. C., Doods, H. N., Schindler, M., & Poyner, D. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704844 · Cited by 57
Yu, L., Hou, J., Fu, F., & Zhang, Y. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.03.009 · Cited by 63
Lipopolysaccharide induces calcitonin gene‐related peptide in the RAW264.7 macrophage cell line
Ma, W., Dumont, Y., Vercauteren, F., & Quirion, R. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03239.x · Cited by 55
Adrenomedullin receptors: molecular identity and function
Hay, D. L., & Smith, D. M. (2001) · Peptides · doi:10.1016/s0196-9781(01)00532-0 · Cited by 62
New therapeutic target in primary headaches ? blocking the CGRP receptor
Edvinsson, L. I. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.3.377 · Cited by 57
“Although the receptors resulting from co-expression of CRLR with either RAMP-1 or -2/3 are functionally distinct and possibly glycosylated to different extents, CGRP and adrenomedullin displayed some crossreactivity for the opposite receptor [29].”
BackgroundmRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lung
Qing, X., Svaren, J., & Keith, I. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.3.l547 · Cited by 55
Coppock, H. A., Owji, A. A., Austin, C., Upton, P. D., JACKSON, M. L., Gardiner, J., Ghatei, M. A., Bloom, S. R., & Smith, D. M. (1999) · Biochemical Journal · doi:10.1042/bj3380015 · Cited by 59
A multi-tissue single-cell expression atlas in cattle
Han, B., Li, H., Zheng, W., Zhang, Q., Chen, A., Zhu, S., Shi, T., Wang, F., Zou, D., Yu, S., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02329-5 · Cited by 62
Role of CGRP-Receptor Component Protein (RCP) in CLR/RAMP Function
Dickerson, I. M. (2013) · Current Protein and Peptide Science · doi:10.2174/13892037113149990057 · Cited by 56
“However, it should be noted that this biphasic response was not observed in oocytes injected with RAMP2 and CLR when incubated with adrenomedullin [1], even though this study also detected a biphasic response to CGRP with RAMP1 and CLR.”
BackgroundMethodResultInfluentialRAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis
Mackie, D. I., Nielsen, N. R., Harris, M., Singh, S., Davis, R. B., Dy, D., Ladds, G., & Caron, K. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905561116 · Cited by 56
“The RAMPs were first identified by virtue of their requirement for promoting the forward translocation of the calcitonin-receptor–like receptor (CLR) from the cytoplasm to the plasma membrane (3).”
BackgroundSerrano, J., Alonso, D. C., Encinas, J. M., López, J. C., Fernández, A. P., Castro‐Blanco, S., Fernández‐Vizarra, P., Richart, A., Bentura, M. L., Santacana, M., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00532-2 · Cited by 57
Mikami, N., Watanabe, K., Hashimoto, N., Miyagi, Y., Sueda, K., Fukada, S., Yamamoto, H., & Tsujikawa, K. (2012) · International Immunology · doi:10.1093/intimm/dxs075 · Cited by 59
Genetic Mapping of the Human C5a Receptor
Geva, A., Lassere, T. B., Lichtarge, O., Pollitt, S. K., & Baranski, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005602200 · Cited by 56
Metadata
- Authors
- McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M.
- Corresponding author
- Foord, Steven M.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6683
- Pages
- 333-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2111112233
- Cited by
- 2,134
- References
- 27
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 50 · 2023: 36 · 2022: 60 · 2021: 57 · 2020: 73 · 2019: 66 · 2018: 66 · 2017: 60 · 2016: 68 · 2015: 61 · 2014: 59 · 2013: 75 · 2012: 69
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, calcitonin gene-related peptide, adrenomedullin, G protein-coupled receptors, receptor trafficking, plasma membrane transport, core glycosylation, ligand specificity, peptide receptors
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Calcitonin, Cell Line, Cloning, Molecular, Cross-Linking Reagents, Glycosylation, Humans, Membrane Proteins, Molecular Sequence Data, Peptides, RNA, Messenger, Tumor Cells, Cultured, Xenopus, Calcitonin Gene-Related Peptide, Gene Expression, Sequence Alignment, 3T3 Cells, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Receptors, Peptide, Receptors, Calcitonin, Receptors, Calcitonin Gene-Related Peptide, Cystic Fibrosis Transmembrane Conductance Regulator, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptors, Adrenomedullin, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.